pharmaphorum

FEBRUARY 25, 2022

The UK pharma sector should emerge from COVID-19 with a great deal of goodwill in the bank, especially after rapidly developing vaccines that are helping to steer the world out of the pandemic. There are plans by the UK health sector containing bold proposals to modernise patient information storage.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Vaccines Patient Care 98

pharmaphorum

JANUARY 31, 2023

Despite this, pharmaceutical companies have not won over public trust. A recent study found that only 48% of participants expressed trust in pharmaceutical companies. This lack of trust in such a crucial industry can lead to decreased compliance, poor treatment adherence, and negative health outcomes for patients.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Communication 52

pharmaphorum

DECEMBER 21, 2021

In early 2020, health officials were cautious about forecasting a COVID-19 vaccine timeline to the public, as vaccine discovery was a historically laborious process that took years (if not decades). Yet a successful COVID-19 vaccine gained emergency approval in just 11 months, a blistering pace that likely saved millions of lives.

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies Vaccines Communication 115

pharmaphorum

JANUARY 27, 2023

Having previously spoken with Dr Mullen three years ago when she was country medical director for the UK & Ireland at GSK – on the topic of patient centricity and embedding that focus within the core of a pharmaceutical company – our recent interview provided some interesting insights into the changing landscape of the industry.

Pharmaceutical Companies 110

Pharmaceutical Companies Pharmaceutical Companies Vaccines Documentation 110

pharmaphorum

SEPTEMBER 9, 2021

Public health agencies and pharma pivoted in countless ways, from decentralising clinical trials and accelerating research and development, to enabling remote care and remote working with rapid digitisation. And we transformed so quickly because the key players communicated and collaborated. About the author.

Patient Care 52

Patient Care Pharmaceutical Companies Pharmaceutical Companies Communication 52

European Pharmaceutical Review

JUNE 16, 2023

With the adoption of digital technologies gaining traction in many industries, pharmaceutical companies must take advantage of digitalisation within its research and development (R&D) sector. Using digital means we can streamline communications, facilitate better patient engagement, and ultimately improve retention rates.

Communication 98

Communication Pharmaceutical Companies Pharmaceutical Companies Patient Care 98